Yanmei Hu - Concepedia

Author

Yanmei Hu

University of Arizona ORCID

Also Known As

Haiming Jiang, Y Hu, Y. Hu, Y.‐H. HU, Y.‐H. Hu, Yajin Hu, Yan Jessie Zhang, Yanmei Hu, Yaowei Hu

113

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

University of Arizona University of South Florida Rutgers, The State University of New Jersey National and Kapodistrian University of Athens Utah State University

About

Yanmei Hu is an author at University of Arizona specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	389
2	Engineering	4	4	125
3	Biochemistry	3	3	117
4	Natural Sciences	2	2	74
5	Social Sciences	1	1	43

Yanmei Hu

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease Chunlong Ma, M. Sacco, Brett L. Hurst, Cell Research	2020	870
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L M. Sacco, Chunlong Ma, Panagiotis Lagarias, Science Advances	2020	390
Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir Yanmei Hu, Eric M. Lewandowski, Haozhou Tan, ACS Central Science	2023	288
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors Chunlong Ma, Yanmei Hu, Julia A. Townsend, ACS Pharmacology & Translational Science	2020	264
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay Chunlong Ma, M. Sacco, Zilei Xia, ACS Central Science	2021	191
The <i>in vitro</i> antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor Yanmei Hu, Xiangzhi Meng, Fushun Zhang, Emerging Microbes & Infections	2021	185
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors Naoya Kitamura, M. Sacco, Chunlong Ma, Journal of Medicinal Chemistry	2021	156
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity Chunlong Ma, Zilei Xia, M. Sacco, Journal of the American Chemical Society	2021	143
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses Yanmei Hu, Chunlong Ma, Tommy Szeto, ACS Infectious Diseases	2021	115
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir Zilei Xia, M. Sacco, Yanmei Hu, ACS Pharmacology & Translational Science	2021	96

Page 1